Skip to main content

Xponance, Inc.

SEC CIK
0001637541
Latest filing
Aug 10, 2026

DYN holding history

Dyne Therapeutics, Inc. in every 13F filed by Xponance, Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

DYN overviewAll 13F holders of DYNFull Q2 2026 holdings

Shares (Q2 2026)
13,436
Value
$298.4K
% of portfolio
<0.1%
Quarters held
2
Since Q1 2026
Holdings of DYN by Xponance, Inc., by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202613,436$298.4K<0.1%+1,228+10.1%AddedHolders
Q1 202612,208$221.3K<0.1%+12,208NewHolders